Change the future of compounding pharmacy with us.

General Info

  1. April 23, 2024

    Ohio state senator tours Lee Silsby Pharmacy, gets the low-down on compounding issues

    Ohio State Senator Kent Smith, minority whip and longtime legislator, paid a visit to Lee Silsby Compounding Pharmacy in late April. Prior to his visit, Smith had a limited background on the world of compounding. Steven Dufala, general manager and pharmacist-in-charge, kicked off the tour with a brief explanation of what compounding is and the patients we serve.

    While walking through our state-of-the-art facility, Nancy Fingerhut, director of quality assurance and regulatory affairs, took the time to explain the various measures we have in place to ensure quality and safety. She brought up the significant impact recent regulatory changes have had on the industry, and what we have done as a company to meet those

    Read More
  2. April 18, 2024

    Podcast: Clearing the air on compounding GLP1 drugs

    The whole issue of compounding GLP-1 agonists like semaglutide is fraught with land mines and misinformation — disinformation, even.

    It's good, then, that the Game Changers Pharmacotherapy Podcast had a couple of guests who know what they're talking about to clear some of the air: Tenille Davis, PharmD, RPh (chief advocacy officer for the Alliance for Pharmacy Compounding) and Scott Brunner, CAE (CEO of APC). The host — Geoff Wall, PharmD — has the chops, too; he's a professor of pharmacy practice at Drake University.

    It covers everything you need to know about compounding GLP-1s, including access, cost, and how shortages come into play. Even better, you might be able to get a half-hour of CPE credit, too!

    Check out "Compounded GLP1s" on the Game Changers podcast — click here or check your favorite podcast app.

    Read More
  3. April 15, 2024

    Revelation Pharma Appoints Brad Leach as Senior Vice President of 503B

    Tampa, FL - April 15, 2024- Revelation Pharma, a leading national network of 503A and 503B compounding pharmacies dedicated to delivering innovative, high quality, and customized medications and services, proudly announces Brad Leach as their new Senior Vice President, 503B.

    With over three decades of acute care experience, including more than 25 years dedicated to the compounding pharmacy industry, Mr. Leach brings a wealth of knowledge garnered from Fortune 500 healthcare corporations to PE-backed organizations. His extensive expertise has been honed through adept navigation of regulatory shifts, evolving from pre-797 regulations to today’s dynamic 503B market landscape.

    Recognized for driving commercial growth and operational excellence, Mr. Leach boasts a proven track record of effectively building and leading teams to success. His multifaceted skill set spans business strategy, marketing, customer service, and new product development.

    Prior to joining Revelation Pharma,

    Read More
  4. March 29, 2024

    Proud to be Certified™ by Great Place To Work®

    FOR IMMEDIATE RELEASE

    REVELATION PHARMA Attains Prestigious Great Place To Work Certification™ for 2024-2025 

    Castle Rock, Colorado – March 29, 2024 – Revelation Pharma is thrilled to announce its official certification as a Great Place To Work® for the 2024-2025 period. This esteemed recognition marks the culmination of dedicated efforts and reflects the unwavering commitment of every member of the Revelation team to foster a positive and supportive workplace environment.

    As stated by Susann Caputo, Senior Vice President of Human Resources at Revelation Pharma, "Achieving certification as a Great Place to Work is a significant accomplishment that reflects the dedication and efforts of every member of our team. It's a validation of our commitment to creating a positive and supportive environment where every individual feels valued, empowered, and inspired to do their best work."

    The Great Place To Work Certification™ is awarded based entirely on feedback

    Read More
Page